These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9620922)

  • 1. Risk factors for rifampin mono-resistant tuberculosis.
    Ridzon R; Whitney CG; McKenna MT; Taylor JP; Ashkar SH; Nitta AT; Harvey SM; Valway S; Woodley C; Cooksey R; Onorato IM
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1881-4. PubMed ID: 9620922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for rifampin-monoresistant tuberculosis: A case-control study.
    Sandman L; Schluger NW; Davidow AL; Bonk S
    Am J Respir Crit Care Med; 1999 Feb; 159(2):468-72. PubMed ID: 9927359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS.
    Lutfey M; Della-Latta P; Kapur V; Palumbo LA; Gurner D; Stotzky G; Brudney K; Dobkin J; Moss A; Musser JM; Kreiswirth BN
    Am J Respir Crit Care Med; 1996 Feb; 153(2):837-40. PubMed ID: 8564140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
    Nolan CM; Williams DL; Cave MD; Eisenach KD; el-Hajj H; Hooton TM; Thompson RL; Goldberg SV
    Am J Respir Crit Care Med; 1995 Sep; 152(3):1067-71. PubMed ID: 7663785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 10. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M; Ouedraogo SM; Diagbouga S; Coulibaly G; Achi V; Domoua K; N'Dathz M; Yapi A
    Rev Mal Respir; 2000 Apr; 17(2):477-80. PubMed ID: 10859766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective malabsorption and the origin of mono-rifampin-resistant Mycobacterium tuberculosis.
    Perlman DC; Salomon N
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1213. PubMed ID: 8887622
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of clinical characteristics between rifampin-dependent and rifampin- resistant patients with pulmonary tuberculosis].
    Li Y; Tan S; Luo C; Li Y; Qin H; Feng Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):287-9. PubMed ID: 23443791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
    Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A continuing survey of drug-resistant tuberculosis, New York City, April 1994.
    Fujiwara PI; Cook SV; Rutherford CM; Crawford JT; Glickman SE; Kreiswirth BN; Sachdev PS; Osahan SS; Ebrahimzadeh A; Frieden TR
    Arch Intern Med; 1997 Mar; 157(5):531-6. PubMed ID: 9066457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997.
    Frieden TR; Munsiff SS; Ahuja SD
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):116. PubMed ID: 17217141
    [No Abstract]   [Full Text] [Related]  

  • 19. Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi: results of a drug resistance survey.
    Sanders M; Van Deun A; Ntakirutimana D; Masabo JP; Rukundo J; Rigouts L; Fissette K; Portaelst F
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):178-83. PubMed ID: 16499257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
    Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.